FindTrial
Sign In

Comparison of two score system namely Modified ROX and ROX for predicting the outcome of an oxygen delivery device known as high flow nasal oxygen( HFNO) therapy in patients presenting with acute respiratory distress.

Comparison of modified rox index score and rox index score for early prediction of HFNC therapy outcome in ards: A prospective observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039377
Enrollment
100
Registered
2022-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J80- Acute respiratory distress syndrome

Interventions

None listed

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Acute Hypoxemic Respiratory failure, defined having more than 22 breaths per minute, P/F ratio less than 300.

Exclusion criteria

Exclusion criteria: 1. Acute Respiratory failure secondary to Asthma. 2. COPD exacerbation. 3. Cardiogenic Pulmonary edema. 4. Patients on high vasopressor support. 5. GCS less than 12. 6. Arrhythmias. 7. Recent nasal bleed. 8. CSF Rhinorrhea. 9. Patients with do not intubate order.

Design outcomes

Primary

MeasureTime frame
To compare Modified ROX index and ROX index score to predict the outcome of HFNO (High Flow Nasal Oxygen) therapy.Timepoint: 1 hour after initiation of HFNO(High Flow Nasal Oxygen) therapy followed readings taken after 2 hours, 4 hours,8 hours, 12 hours, 18 hours, 24 hours and 48 hours.—

Secondary

MeasureTime frame
To find out if presence of any comorbid conditions like diabetes mellitus, hypertension, kidney disease, thyroid disorder, chronic lung conditions, immunocompromised states leads to any change in ROX-HR cut-off valuesTimepoint: 1 hour after initiation of HFNO(High Flow Nasal Oxygen) therapy followed readings taken after 2 hours, 4 hours,8 hours, 12 hours, 18 hours, 24 hours and 48 hours. .—

Countries

India

Contacts

Public ContactDr Ankur Sharma

AIIMS Jodhpur

ankuranaesthesia@gmail.com9654045653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026